All Stories

  1. Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia

    Article • Pediatrics International, October 2017, Wiley

    Nakayama Hideki

  2. Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study

    Article • Journal of the American Heart Association, July 2017, Wolters Kluwer Health

    Nakayama Hideki

  3. Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study

    Article • Pediatric Blood & Cancer, February 2017, Wiley

    Nakayama Hideki